Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today ...

The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its ...

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) ...

Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...

Pro Forma Revenue Expected to exceed $20M (~4x 2024 Revenue)Wattbike Air-Pro Sells 700+ Units / ~$2.5M in UK Commercial ...

Critical Access Hospital IT, clinical, and financial users cite repackaged health-system solutions, misaligned implementation ...

Ombudsman’s investigation triggers review of cancer treatment wait times at NHS Trust An investigation by England’s Health ...

Sanofi’s Teizeild wins EU approval as the first disease-modifying therapy to delay stage 3 type 1 diabetes in people eight ...

Emmecell, a clinical-stage biotechnology company pioneering magnetic cell delivery technologies for ophthalmic disease, today announced the appointment of Ramin Valian as Chief Executive Officer. A ...

This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approvedMILAN--(BUSINESS WIRE)--#CGT--With the decision by ...

Responding to the announcement from NHS England that a new national registry for AI note taking tools has been established, Dr Layla McCay, director of policy at the NHS Confederation, ...

GUILDFORD, SURREY / ACCESS Newswire / January 16, 2026 / CelLBxHealth plc (AIM:CLBX), a leader in circulating tumour cell (CTC) intelligence, with tests and services supporting research, drug ...